How are REMS designed to help drug sponsors?

How are REMS designed to help drug sponsors?

• A. increase market share
• B. reduce risks or harms
• C. mitigate all adverse events
• D. to modify manufacturing processes

Answer: (B)

REMS are regulatory tools that focus on minimizing the risks associated with certain drugs with serious safety concerns. They are designed so that patients can benefit from the therapy while safety is actively managed through specific actions by prescribers, pharmacies, and patients—such as education, restricted distribution, required monitoring, or patient registries. By demonstrating that these safety measures effectively reduce harm, sponsors support continued access to the drug under controlled conditions and satisfy regulatory expectations. REMS aim to lower the incidence and severity of adverse events, not to eliminate all adverse events, and they aren’t about changing how a drug is manufactured.

REMS are regulatory tools that focus on minimizing the risks associated with certain drugs with serious safety concerns. They are designed so that patients can benefit from the therapy while safety is actively managed through specific actions by prescribers, pharmacies, and patients—such as education, restricted distribution, required monitoring, or patient registries. By demonstrating that these safety measures effectively reduce harm, sponsors support continued access to the drug under controlled conditions and satisfy regulatory expectations. REMS aim to lower the incidence and severity of adverse events, not to eliminate all adverse events, and they aren’t about changing how a drug is manufactured.